boustead spore - BSTGF

BSTGF

Close Chg Chg %
0.00 0.00 0.00%

Closed Market

0.00

0.00 (0.00%)

Volume: 100.00

Last Updated:

Nov 3, 2025, 11:04 AM EDT

Company Overview: boustead spore - BSTGF

BSTGF Key Data

Open

$0.00

Day Range

0.00 - 0.00

52 Week Range

N/A - N/A

Market Cap

N/A

Shares Outstanding

504.72M

Public Float

245.35M

Beta

-2.26

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

$0.05

Yield

N/A

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

N/A

 

BSTGF Performance

No Data Available

BSTGF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About boustead spore - BSTGF

Boustead Singapore Ltd. operates as an investment holding company. The firm engages in the engineering and development of infrastructures. It operates through the following segments: Energy-Related Engineering, Real Estate Solutions, Geo-Spatial Technology, Healthcare technology and HQ Activities. The Energy-Related Engineering segment relates to the design, engineering, and supply of systems to the oil and gas, petrochemical, and solid waste energy recovery sectors. The Real Estate Solutions segment includes the provision of design and builds expertise for industrial facilities and design, building and lease arrangements for industrial facilities. The Geo-Spatial Technology segment specializes in Esri geographic information systems and location intelligence. The Healthcare technology segment engages in distribution and services related to niche medical solutions that address age-related chronic diseases and mobility issues, with a focus on rehabilitative care, sleep care sports science in the Asia Pacific. The HQ Activities segment manages the investment portfolio to maximize shareholders' returns. The company was founded by Edward Boustead in 1828 and is headquartered in Singapore.

BSTGF At a Glance

Boustead Singapore Ltd.
Edward Boustead Centre
Singapore, Central Singapore 408832
Phone 65-6747-0016 Revenue 393.89M
Industry Engineering & Construction Net Income 71.03M
Sector Industrial Services Employees 1,358
Fiscal Year-end 03 / 2026
View SEC Filings

BSTGF Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio N/A
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA N/A
Enterprise Value to Sales N/A
Total Debt to Enterprise Value N/A

BSTGF Efficiency

Revenue/Employee 290,051.682
Income Per Employee 52,302.597
Receivables Turnover 2.848
Total Asset Turnover 0.481

BSTGF Liquidity

Current Ratio 1.404
Quick Ratio 1.386
Cash Ratio 0.839

BSTGF Profitability

Gross Margin 44.23
Operating Margin 18.757
Pretax Margin 27.039
Net Margin 18.032
Return on Assets 8.682
Return on Equity 17.605
Return on Total Capital 15.101
Return on Invested Capital 16.679

BSTGF Capital Structure

Total Debt to Total Equity 8.736
Total Debt to Total Capital 8.034
Total Debt to Total Assets 4.659
Long-Term Debt to Equity 4.846
Long-Term Debt to Total Capital 4.456
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Boustead Spore - BSTGF

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
468.57M 408.72M 570.64M 393.89M
Sales Growth
-6.85% -12.77% +39.62% -30.97%
Cost of Goods Sold (COGS) incl D&A
361.14M 294.44M 402.07M 219.67M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
8.57M 7.26M 8.29M 6.61M
Depreciation
8.07M 7.26M 6.23M 6.49M
Amortization of Intangibles
501.98K 4.37K 2.07M 118.82K
COGS Growth
-3.65% -18.47% +36.56% -45.37%
Gross Income
107.42M 114.28M 168.57M 174.22M
Gross Income Growth
-16.21% +6.39% +47.50% +3.35%
Gross Profit Margin
+22.93% +27.96% +29.54% +44.23%
2022 2023 2024 2025 5-year trend
SG&A Expense
81.22M 80.23M 101.12M 100.34M
Research & Development
- - - -
-
Other SG&A
81.22M 80.23M 101.12M 100.34M
SGA Growth
-0.11% -1.21% +26.03% -0.77%
Other Operating Expense
- - - -
-
Unusual Expense
247.65K (382.05K) 720.39K 1.21M
EBIT after Unusual Expense
25.96M 34.43M 66.73M 72.67M
Non Operating Income/Expense
6.13M 24.00M 17.78M 35.58M
Non-Operating Interest Income
6.01M 9.55M 13.84M 15.05M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
1.45M 2.28M 1.23M 1.74M
Interest Expense Growth
-48.43% +57.27% -46.14% +42.03%
Gross Interest Expense
1.45M 2.28M 1.23M 1.74M
Interest Capitalized
- - - -
-
Pretax Income
30.64M 56.15M 83.28M 106.50M
Pretax Income Growth
-78.16% +83.25% +48.30% +27.89%
Pretax Margin
+6.54% +13.74% +14.59% +27.04%
Income Tax
12.20M 14.76M 21.03M 17.37M
Income Tax - Current - Domestic
12.91M 15.26M 21.64M 1.62M
Income Tax - Current - Foreign
- - - 16.34M
-
Income Tax - Deferred - Domestic
(717.01K) (505.04K) (617.80K) (585.12K)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
28.76M 40.90M 53.65M 74.79M
Minority Interest Expense
6.09M 7.91M 5.93M 3.76M
Net Income
22.67M 32.98M 47.72M 71.03M
Net Income Growth
-72.60% +45.48% +44.68% +48.84%
Net Margin Growth
+4.84% +8.07% +8.36% +18.03%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
22.67M 32.98M 47.72M 71.03M
Preferred Dividends
- - - -
-
Net Income Available to Common
22.67M 32.98M 47.72M 71.03M
EPS (Basic)
0.0469 0.0687 0.0999 0.1462
EPS (Basic) Growth
-72.46% +46.48% +45.41% +46.35%
Basic Shares Outstanding
483.26M 480.24M 477.47M 485.73M
EPS (Diluted)
0.0469 0.0687 0.0999 0.1462
EPS (Diluted) Growth
-72.44% +46.48% +45.41% +46.35%
Diluted Shares Outstanding
483.26M 480.24M 477.47M 485.73M
EBITDA
34.77M 41.31M 75.74M 80.49M
EBITDA Growth
-41.16% +18.80% +83.34% +6.27%
EBITDA Margin
+7.42% +10.11% +13.27% +20.43%

Boustead Spore in the News